Chia-Yi Chu
An unmet medical need is the control of metastases of prostate cancer that cause the lethal form of this disease. Dr. Chu has discovered metastasis-initiating prostate cancer cells that circulate...Read More
Michael Evans
Molecular imaging of prostate cancer to determine sites of metastasis in recurrent patients is an unmet medical need. Dr. Evans is exploiting the activation of two cancer-causing genes (MYCand PI3K)...Read More
Geraldine Gueron
Proteomics is the study of proteins in a cell and their interactions with each other. The overall goal of this research is to use proteomics for the identification of predictive...Read More
Lauren Harshman
Immunotherapy has come of age with the approval of Sipuleucel-T (Provenge) and the introduction of ipilimumab (Yervoy) and other similar immune modulators into clinical trials for advanced metastatic prostate cancer....Read More
Emmanuel Antonarakis
Understanding resistance to new treatments for advanced, metastatic prostate cancer represents an unmet medical need. Dr. Antonarakis is studying genetic variants of the target of these new medicines as one...Read More
Syed Adnan Ali
Over 1 million prostate biopsies are performed annually in the United States annually while only a quarter present with cancer. Most of these biopsy procedures are triggered by abnormal PSA...Read More
Shuang Zhao, MD
Long non-coding RNAs (lncRNAs) such as PCAT1 and SChLAP1 have emerged as key molecular drivers, biomarkers, and potential therapeutic targets in aggressive prostate cancer. Currently only a small number of...Read More
Rendong Yang
Next generation sequencing (NGS) is a growing class of innovative new gene sequencing techniques that can sequence millions of fragments of DNA simultaneously. NGS results expand our understanding of complex...Read More
Adam Sowalsky
Genomic analysis of cancer tissue has enabled investigators to study mechanisms of resistance to the androgen receptor (AR) inhibitor Xtandi® in men with prostate cancer. Dr. Adam Sowalsky will use...Read More